Kitchen foil vs bed sheet: which boosts jaundice treatment best?
NCT ID NCT07266246
First seen Jun 27, 2026 · Last updated Sep 15, 2026 · Updated 2 times
Summary
This study tested whether adding reflective materials like aluminum foil or white cloth around babies during light therapy for jaundice helps lower bilirubin faster. 81 newborns with mild jaundice were randomly assigned to standard therapy, therapy with white cloth reflectors, or therapy with aluminum foil reflectors. The goal was to see which method shortens treatment time and reduces side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
81 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
36 to 42 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Neonates with total serum bilirubin levels between 15-20 mg/dL * Gestational age between 35-42 weeks * Birth weight between 2500-4000 g * APGAR score of 7-10 at the 1st and 5th minutes after birth * Fed with breast milk and/or formula * Written and verbal informed consent obtained from parents * Neonates who can be reached on the first day of phototherapy treatment Exclusion Criteria: * Neonates with Rh incompatibility * Neonates with ABO incompatibility * Neonates with any congenital anomaly * Neonates with asphyxia * Neonates receiving intensive (double) phototherapy * Neonates with glucose-6-phosphate dehydrogenase (G6PD) deficiency * Neonates with serum bilirubin levels close to the exchange transfusion threshold * Neonates whose parents do not consent to participation in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neonatal hyperbilirubinemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Play-Based coaching program help preterm babies thrive at home?
- Robot assistant aims to cut nurse stress
- Can a bacterial extract shield preterm babies from lung infections?
- Nature videos through VR goggles tested to calm C-Section recovery
- Parents take the syringe: a new way to feed premature babies
- Brain injury in older adults: do electrolytes hold clues to recovery?